Recombinant Interleukin-21
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Recombinant Interleukin-21, covering 2008-09-05 to 2017-03-01. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer [Phase 2]